NIH will fund investigator-initiated multi-site or decentralized clinical trials relevant to its mission, supporting planning and implementation over up to 7 years using a milestone-driven UG3/UH3 grant mechanism.
NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
NIH funds multisite trials and observational studies using clinical research networks for infants, children, women, pregnant and lactating women, and people with disabilities through milestone-based phases.
Supports investigator-initiated, milestone-driven clinical trials requiring enhanced oversight for up to 7 years, with mechanistic studies as applicable and one trial per application.
NHLBI seeks a Data Coordinating Center to manage data and provide statistical support for multi-site clinical trials, requiring collaboration with a Clinical Coordinating Center.